RESUMEN
In Parkinson's disease (PD), several efforts have been spent in order to find biochemical parameters able to identify the progression of the pathological processes at the basis of the disease. It is already known that advanced PD patients manifesting dyskinesia are featured by the high homovanillic acid (HVA)/dopamine (DA) ratio, suggesting the increased turnover of DA in these patients. Less clear is whether similar changes affect mild and moderate stages of the disease (between 1 and 2.5 of Hoehn & Yahr -H&Y- stage). Hence, here we tested whether cerebrospinal fluid (CSF) concentrations of DA and its major metabolites, either 3,4-dihydroxyphenylacetic acid (DOPAC) or HVA, correlate with motor performance in mild and moderate PD patients. CSF samples were collected after 2 days of anti-PD drugs washout, via lumbar puncture (LP) performed 130 min following administration of oral levodopa (LD) dose (200 mg). LP timing was determined in light of our previous tests clarifying that 2 h after oral LD administration CSF DA concentration reaches a plateau, which was un-respective of PD stage or duration. DA, DOPAC and HVA were assayed by high performance liquid chromatography in a group of 19 patients, distributed in two groups on the basis of the H&Y stage with a cut-off of 1.5. In these PD patients, HVA was correlated with DOPAC (R = 0,56, p < 0,01) and both HVA and DOPAC CSF levels increased in parallel with the motor impairment. More importantly, HVA correlated with motor impairment measured by the Unified Parkinson's Disease Score -III (UPDRS) (R = 0.61; p < 0.0001). The present findings showed the early alteration of the DA pre-synaptic machinery, as documented by the progressive increase of CSF HVA concentrations, which also correlated with PD motor impairment. Therefore, we suggest the potential use of measuring the CSF HVA level as a possible biomarker of PD stage changes in order to monitor the effectiveness of PD-modifying pharmacological therapies.
Asunto(s)
Progresión de la Enfermedad , Ácido Homovanílico/líquido cefalorraquídeo , Enfermedad de Parkinson/líquido cefalorraquídeo , Enfermedad de Parkinson/diagnóstico , Anciano , Antiparkinsonianos/uso terapéutico , Biomarcadores/líquido cefalorraquídeo , Femenino , Humanos , Levodopa/uso terapéutico , Masculino , Persona de Mediana Edad , Trastornos de la Destreza Motora/líquido cefalorraquídeo , Trastornos de la Destreza Motora/diagnóstico , Trastornos de la Destreza Motora/tratamiento farmacológico , Enfermedad de Parkinson/tratamiento farmacológicoRESUMEN
Neurotransmitters are essential in young children for differentiation and neuronal growth of the developing nervous system. We aimed to identify possible factors related to secondary neurotransmitter abnormalities in pediatric patients with neurological disorders. We analyzed cerebrospinal fluid (CSF) and biogenic amine metabolites in 56 infants (33 males, 23 females; mean age 5.8mo [SD 4.1mo] range 1d-1y) with neurological disorders whose aetiology was initially unknown. Patients were classified into three clinical phenotypes: epileptic encephalopathy, severe motor impairment, and non-specific manifestations. All patients showed normal results for screening of inborn errors of metabolism. We report clinical, neuroimaging, and follow-up data. Among the patients studied, 10 had low homovanillic acid (HVA) levels and in four patients, 5-hydroxyindoleacetic acid (5-HIAA) was also reduced. Patients with neonatal onset had significantly lower levels of HVA than a comparison group. HVA deficiency was also associated with severe motor impairment and the final diagnosis related to neurodegenerative disorders. 5-HIAA values tended to be decreased in patients with brain cortical atrophy. The possibility of treating patients with L-Dopa and 5-hydroxytryptophan, in order to improve their neurological function and maturation, may be considered.
Asunto(s)
5-Hidroxitriptófano/líquido cefalorraquídeo , Encéfalo/patología , Epilepsia , Ácido Homovanílico/líquido cefalorraquídeo , Ácido Hidroxiindolacético/líquido cefalorraquídeo , Trastornos de la Destreza Motora , Enfermedades del Sistema Nervioso , Pterinas/líquido cefalorraquídeo , Atrofia/patología , Electroencefalografía , Epilepsia/líquido cefalorraquídeo , Epilepsia/diagnóstico , Epilepsia/etiología , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Trastornos de la Destreza Motora/líquido cefalorraquídeo , Trastornos de la Destreza Motora/etiología , Trastornos de la Destreza Motora/fisiopatología , Enfermedades del Sistema Nervioso/líquido cefalorraquídeo , Enfermedades del Sistema Nervioso/complicaciones , Enfermedades del Sistema Nervioso/diagnóstico , Fenotipo , Índice de Severidad de la EnfermedadAsunto(s)
Encéfalo/patología , Encéfalo/fisiopatología , Cardiolipinas/metabolismo , Colesterol/metabolismo , Demencia/líquido cefalorraquídeo , Demencia/microbiología , Neurosífilis/líquido cefalorraquídeo , Fosfatidilcolinas/metabolismo , Adulto , Atrofia/líquido cefalorraquídeo , Atrofia/diagnóstico , Atrofia/microbiología , Encéfalo/microbiología , Cardiolipinas/análisis , Colesterol/análisis , Demencia/diagnóstico , Progresión de la Enfermedad , Reacciones Falso Negativas , Alucinaciones/líquido cefalorraquídeo , Alucinaciones/microbiología , Humanos , Inyecciones Intravenosas , Imagen por Resonancia Magnética , Masculino , Trastornos de la Memoria/líquido cefalorraquídeo , Trastornos de la Memoria/microbiología , Trastornos de la Destreza Motora/líquido cefalorraquídeo , Trastornos de la Destreza Motora/microbiología , Trastornos Neurocognitivos/líquido cefalorraquídeo , Trastornos Neurocognitivos/diagnóstico , Trastornos Neurocognitivos/microbiología , Neurosífilis/diagnóstico , Penicilinas/administración & dosificación , Trastornos de la Personalidad/líquido cefalorraquídeo , Trastornos de la Personalidad/diagnóstico , Trastornos de la Personalidad/microbiología , Fosfatidilcolinas/análisis , Trastornos del Habla/líquido cefalorraquídeo , Trastornos del Habla/microbiología , Lóbulo Temporal/microbiología , Lóbulo Temporal/patología , Lóbulo Temporal/fisiopatología , Resultado del Tratamiento , Treponema pallidum/fisiologíaRESUMEN
Patterns of leukoaraiosis were analyzed on both T2-weighted fast fluid-attenuated inversion-recovery and 3D T1-weighted sequences in 23 community-dwelling older subjects with mild cognitive impairment. Mobility assessment had allowed their classification into higher and lower mobility groups (P<0.0001). Lower mobility appeared correlated with frontal subependymal lesions (P=0.0005). The absence of marked ventriculomegaly, any thick caps, deep white matter lesions curved along the ventricles bodies, large deep white matter lesions, deep grey matter leukoaraiosis was an hallmark of the higher mobility group (P<0.0001). High resolution MRI demonstrated regular patterns of the subependymal lesions and detected perivascular distribution in other forms of leukoaraiosis. It suggests that the underlying mechanism of mobility decline in the elderly may be impairment of cerebrospinal fluid dynamics with cerebral small vessel disease.